Ara-290 (16 mg Vial)

Reconstitution and handling reference for Ara-290 (16 mg Vial). It sets out how much bacteriostatic water to add, what concentration that produces, how the dose maps onto U-100 syringe units, and how the vial should be stored before and after reconstitution.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Ara-290 (16 mg Vial)

Synonyms/Alias: Ara-290

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Reconstitution and handling reference for Ara-290 (16 mg Vial). It sets out how much bacteriostatic water to add, what concentration that produces, how the dose maps onto U-100 syringe units, and how the vial should be stored before and after reconstitution.

Quickstart

Reconstitute: Add 2.0 mL bacteriostatic water β†’ 8 mg/mL concentration.

Target dose: 4 mg once daily subcutaneously (after initial 2 mg titration).

Easy measuring: At 8 mg/mL, 1 unit = 0.01 mL = 80 mcg on a U-100 insulin syringe.

Storage: Lyophilized: refrigerate at 2–8 Β°C (35.6–46.4 Β°F) or freeze at βˆ’20 Β°C (βˆ’4 Β°F); reconstituted: refrigerate and use within 28 days.

Notes

Practical considerations for consistency and safety. Use a new sterile insulin syringe for each injection; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy [8]. Inject slowly; wait a few seconds before withdrawing the needle. Document daily dose and injection site to maintain consistency. No clinically significant adverse effects were reported at 4 mg/day in 28-day clinical trials [3].

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Week 1
Daily Dose: 2 mg (2,000 mcg) | Units (per injection) (mL): 25 units (0.25 mL)
Weeks 2–8 (or up to 16)
Daily Dose: 4 mg (4,000 mcg) | Units (per injection) (mL): 50 units (0.50 mL)
Long-term Storage Conditions
Lyophilized: refrigerate at 2–8 Β°C (35.6–46.4 Β°F) or freeze at βˆ’20 Β°C (βˆ’4 Β°F); reconstituted: refrigerate and use within 28 days.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Ara-290, 16 mg each): 8 weeks β‰ˆ 14 vials

12 weeks β‰ˆ 21 vials

16 weeks β‰ˆ 28 vials

Insulin Syringes (U-100): Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution. 8 weeks (14 vials): 28 mL β†’ 3 Γ— 10 mL bottles

12 weeks (21 vials): 42 mL β†’ 5 Γ— 10 mL bottles

16 weeks (28 vials): 56 mL β†’ 6 Γ— 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs β†’ recommend 2 Γ— 100-count boxes

12 weeks: 168 swabs β†’ recommend 2 Γ— 100-count boxes

16 weeks: 224 swabs β†’ recommend 3 Γ— 100-count boxes

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China